Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-20 · accession 0001601485-22-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-25 | 2022-05-20+ | ELTX | Venkatesan Jay | See Remarks, Dir | P - Purchase | $1.23 | +82.2K | 1.72M | +5% | +$101.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-20 | P | A | 50,000 | $1.23 | 1,689,257 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-24 | P | A | 32,200 | $1.24 | 1,721,457 | D | — | — |